Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline.

MLA

Korde, Larissa A., et al. “Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 39, no. 13, May 2021, pp. 1485–505. EBSCOhost, https://doi.org/10.1200/JCO.20.03399.

APA

Korde, L. A., Somerfield, M. R., Carey, L. A., Crews, J. R., Denduluri, N., Hwang, E. S., Khan, S. A., Loibl, S., Morris, E. A., Perez, A., Regan, M. M., Spears, P. A., Sudheendra, P. K., Symmans, W. F., Yung, R. L., Harvey, B. E., & Hershman, D. L. (2021). Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 39(13), 1485–1505. https://doi.org/10.1200/JCO.20.03399

Chicago

Korde, Larissa A, Mark R Somerfield, Lisa A Carey, Jennie R Crews, Neelima Denduluri, E Shelley Hwang, Seema A Khan, et al. 2021. “Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 39 (13): 1485–1505. doi:10.1200/JCO.20.03399.